Skip to main content

Corundum Group, Inc.

SEC CIK
0001486083
Latest filing
Aug 7, 2026

ABT holding history

Abbott Laboratories in every 13F filed by Corundum Group, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABT overviewAll 13F holders of ABTFull Q2 2026 holdings

Shares (Q2 2026)
9,802
Value
$889.4K
% of portfolio
0.3%
Quarters held
22
Since Q1 2021
Holdings of ABT by Corundum Group, Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20269,802$889.4K0.3%−122−1.2%ReducedHolders
Q1 20269,924$1.02M0.3%+305+3.2%AddedHolders
Q4 20259,619$1.21M0.4%+894+10.2%AddedHolders
Q3 20258,725$1.17M0.5%−29−0.3%ReducedHolders
Q2 20258,754$1.19M0.5%−93−1.1%ReducedHolders
Q1 20258,847$1.17M0.6%−4,134−31.8%ReducedHolders
Q4 202412,981$1.47M0.5%+4,193+47.7%AddedHolders
Q3 20248,788$1.00M0.5%−4,101−31.8%ReducedHolders
Q2 202412,889$1.34M0.5%+3,766+41.3%AddedHolders
Q1 20249,123$1.04M0.5%+3,850+73.0%AddedHolders
Q4 20235,273$580.4K0.3%−5,686−51.9%ReducedHolders
Q3 202310,959$1.06M0.6%−983−8.2%ReducedHolders
Q2 202311,942$1.30M0.6%−815−6.4%ReducedHolders
Q1 202312,757$1.29M0.6%+4,345+51.7%AddedHolders
Q4 20228,412$924.0K0.5%−387−4.4%ReducedHolders
Q3 20228,799$851.0K0.5%+227+2.6%AddedHolders
Q2 20228,572$931.0K0.6%+701+8.9%AddedHolders
Q1 20227,871$932.0K0.9%+2,282+40.8%AddedHolders
Q4 20215,589$787.0K0.5%+449+8.7%AddedHolders
Q3 20215,140$607.0K0.5%+257+5.3%AddedHolders
Q2 20214,883$566.0K0.4%−400−7.6%ReducedHolders
Q1 20215,283$633.0K0.5%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.